Professional Documents
Culture Documents
HADIANTI
TROMBOSIS
Blood Vessels. A.) The wall of an artery. B.) The wall of a vein
Faktor-faktor penyebab trombosis: Kolesterol Kompleks im n !n"otoksin Sres #emo"inamik Bakteri "an $ir s Sitokin !n%im rokok
&ato'enesis
Keti"akseimban'an stim lasi trombo'enik "an mekanisme proteksi - Stim lasi berlebi#an "' proteksi normal ata stim lasi normal proteksi berk ran' Hemostasis penyemb #an l ka ()* #ari+ #emostasis primer (trombosit "an $essel+ #emostasis sek n"er (faktor koa' lasi "an antikoa' lan #emostasis tersier (fibrinolisis+
&roteksi trombosis: &rotein , "' kofaktor protein S #ambat -a "an -IIa AT III "an Heparin alfa) antitripsin "an beta. mikro'lobin #ambat /a "an trombin t&A #ambat plasmin melisis fibrin
Trombosis
Masa abnormal "ari konstit en "ara# melal i proses
koa' lasi intral minar sistem $ask lar semasa #i" p0 Trombosis $ena a"ala# trombosis "i "alam $ena &enyakit $ena peri$er terserin' yan' menyebabkan pasien ke "okter a"ala#:
1 Trombosis $ena "alam (Deep -ein T#rombosis2D-T+3 1 Tromboflebitis3 1 &ost T#romboti4 Syn"rome (&TS+ akibat ins fisiensi kat p $ena "alam kronik ber pa:
5 pi'mentasi stasis "an2ata 5 "ermatitis stasis "an2ata 5 lk s stasis0
Pathophysiologic of Thrombosis
Triad of Virchow
abnormality of blood
Plaque ruptures
Venous Hypotonia
Venous stasis
Arterial Thrombosis
Venous Thrombosis
Arterial Thrombosis
Venous Thrombosis
Endothelial Perturbation
Fa4tor risiko
Berba'ai fa4tor yan' berperan seba'ai penyebab
pembent kan saran' trombosit "an kompleks trombinfibrin seba'ai bakal trombosis $ena ter tama a"ala#:
1 1 1 1 1 1 stasis $ena3 #ipotonia $ena3 stat s #iperkoa' labilitas ole# berba'ai penyebab3 stat s trombofilik ole# berba'ai penyebab3 "efisiensi fibrinolysis ole# berba'ai penyebab3 ker sakan en"otel $ena ata en"otel $ena teran4am r sak (en"ot#elial pert rbation+3 1 ker sakan t nika intima $ena0
Causes of Thrombosis
Clinical Conditions Arterial Thrombosis Atherosclerosis Cigarette smo ing !"#ertension Dia$etes Mellitus %o&'(ensit" li#o#rotein cholesterol !"#ertrigl"ceri(emia )ositive *amil" histor" %e*t ventricular *ailure Oral contrace#tives +strogens %i#o#rotein(a) )ol"c"themia !"#erviscosit" s"n(romes Venous Thrombosis General surgery Orthopaedic surgery Arthroscopy Immobility alignancy !epsis In,ur" Congestive !eart -ailure Ne#hrotic s"n(rome O$esit" .aricose veins )ost#hle$itic s"n(rome Oral contrace#tives +strogens Defect of Blood, Protein, or Platelet Antiphospholipid syndrome !tic"y platelet syndrome Cancer procoagulant #CP$ )rotein S (e*ects )rotein C (e*ects A)C resistance (*actor . %ei(en) Antithrom$in (e*ects !e#arin co*actor II (e*ects )lasminogen (e*ects Tissue #lasminogen activators (e*ects )lasminogen activator inhi$itor (e*ects -actors /II (e*ects D"s*i$rinogenemia
S#eci*icit"
%i elihoo( Ratio #ositive (%R2) :;<57 :7<99 ;<>> :><8; 9;<87 93<87 ()+,,
Do##ler ultrasoun( Du#le? 0S1 Conventional 0S1 Color (o##ler 0S1 Com#ression color (o##ler 0S1
334 (38'6=4) 334 (35'6:4) 684 (36'634) 6>4 (3;'6;4) 684 (6>'6;4) 634 (65'664) 6;4 (68'664) 634 (65'664) ()* ((*
1. Gillum RF. Am Heart J. 19 !"11#$%)&1'(')1'(# '. Anderson FA Jr* et al. Ar+h ,ntern -ed.1991"1%1$%)& 9..)9. .. /ilverstein -0* et al. Ar+h ,ntern -ed. 199 "1% $()&% %)%9. #. 1,H 2onsensus 0evelo3ment. JA-A. 19 ( Au4 "'%($()&!##)!#9 %. Giuntini 2* et al. 2hest. 199% Jan"15!$1 /u33l)&.)9/
1. /tein 60* et al. 2hest. 199%"15 $#)&9! '. 7ethen H* et al. Am J 2ardiol. 199!" 5&15(() .. /andler 0A* et al. J R /o+ -ed. 19 9" '$%)&'5.
Thrombus
Embolus
1. 6esavento R* et al. -inerva 2ardioan4iol. 199!"#%$!) )&.(9).!% '. Girard 6* et al. 2hest. 1999"11($#)&95.)95
T#rombo'enesis D-T
Kebanyakan pembent kan tromb s $ena "im lai
"ari pembent kan 6arin' "ari saran' trombosit "an kompleks trombin-fibrin pa"a sin s $ena "i"alam otot ata kat p $ena pa"a $ena "alam meskip n ti"ak a"a ker sakan en"otel $ena3 se#in''a sel "ara# mera# terperan'kap membent k tromb s yan' "iseb t seba'ai tromb s mera# "an kem "ian men6alar ke proksimal0
7e6ala klinis
7e6ala klinis D-T ter'ant n' l asnya keterlibatan $ena3
C Acti3e cancer #ongoing or 0ithin pre3ious 4 months % chemotherapy$ % C Paralysis, paresis or recent plaster immobili5ation of the lo0er e6tremities % C Bedridden for more than 1 days or ma7or surgery 0ithin 8 % 0ee"s % C 9ntire leg s0ollen C Calf s0elling of more than 1 cm 0hen compared 0ith the % asymptomatic leg #measured %, cm belo0 the tibial % tuberosity$ % C Pitting edema greater in the symptomatic leg -& C Collateral non3aricose superficial 3eins C /ocali5ed tenderness along distribution of the deep 3ein , . /o0 system probability, % or & . oderate probability, 1 or more . 2igh probability C Alternati3e diagnosis as or more li"ely than DVT
Negative :egati3e
Positi3e )ositive
Positi3e DVT
&en'obatan
Mo"alitas pen'obatan trombosis $ena9
1 1 1 1 1 1 T#rombolyses3 T#rombe4tomy3 Anti4oa' lants3 Intermittent &ne mati4 ,ompression3 7ra" ally 4ompression sto4kin'3 &er4 taneo s -al$ loplasty B--:+ (s 44ess rate ;<=+0
KID
Definition
Disseminate" intra$as4 lar 4oa' lation (DI,+ is a
4lini4opat#olo'i4 syn"rome in >#i4# >i"esprea" intra$as4 lar 4oa' lation is in" 4e" by pro4oa' lants t#at are intro" 4e" or pro" 4e" in t#e bloo" an" o$er4ome t#e nat ral anti4oa' lant me4#anisms
&at#olo'y
- Diff se m ltior'an blee"in' - Hemorr#a'i4 ne4rosis - Mi4rot#rombi in small bloo" $essels - T#rombi in me"i m an" lar'e bloo" $essels
&at#o'enesis
infectio n !I> ! in7ur y
96posure of blood to tissue 0ith T<
Venom < I? and ?I consentrat Cancer procoagulant Acti3ation platelets,< V dan VIII <ailure of mechanism
Throm$in generation
DIC
Vessel obstruction fibrinolysis <DP=DDimer
OD
bleeding
O<
)atho#h"siolog"
Any causes Precipitating factors )rocoagulant activation
IN-g TN-a I%': !epsis I%'5
+?cessive coagulation activit" Disseminated Thrombosis Coagulation *actors Natural anticoagulant consum#tion consum#tion Ine**ective !emostatic Bleeding s"stem Shoc OD= O< !igh -D)
se3sis8severe infe+tion $any mi+ro9or4anism) trauma $e.4. 3olytrauma* neurotrauma* fat em:olism) or4an destru+tion $e.4. severe 3an+reatitis) mali4nan+y
) solid tumors ) -yelo3roliferative 8 7ym3ho3roliferative mali4nan+ies
o:stetri+al +alamities ) amnioti+ fluid em:olism ) a:ru3tio 3la+entae vas+ular a:normalities ) 7ar4e vas+ular aneurysms severe he3ati+ failure severe to;i+ or immunolo4i+ rea+tions ) sna<e :ites ) re+reational dru4s ) transfusion rea+tions ) trans3lant re=e+tion
Determine score D Platelet D E %,,+,,,.,,B %,,+,,,.% B ',+,,, . & <ibrin mar"er D no increase . ,, moderate increase .&,strong increse.1 Prolong prothrombin time D B 1 .,, E1 B4 . %, E 4. & <ibrinogen le3el B %g=l . ,, E %g=l .%
:o DIC
Consum#tion Coaggulo#ath"
)T ratioB E:<=8 )T4B F374 INRB E:<> a)TT E:<=8 ratioB Trom$osit F:=7<7 B 77 -i$rinogen F:87 B
DICB
Throm$osis (isertai consum#tion coaggulo#ath"
Diagnostic Criteria for O3ert DIC by the International !ociety of Thrombosis and 2emostasis #I!T2$ !ubcommittee on DIC, and for DIC by the Fapanese inistry of 2ealth and Gelfare #F 2G$H
I!T2 0n(erl"ing (isease Blee(ing s"m#tom O- (ue to throm$osis )T -i$rinogen -D) In(is#ensa$le 7 #oint 7 #oint )rolongation o* )T I > secA : #oint I 5 secA = #oints J: g/%A : #oint Mil( increase A : #oint Mo(erate increase A = #oints Strong increase A > #oints J :77A : #oint J 87 A = #oints Overt'DIC I 8 #oints : #oint
F 2G !)T(G)B : #ointH !)T(2)B 7 #oint : #oint )T ratio I :<=8B : #oint I :<5;B = #oints J :<8 g/%B : #oint J :<7 g/%B = #oints I :7 mg/m%B : #oint I =7 mg/m%B = #oints I 97 mg/m%B > #oints !T)(2)B 7 #oint !)T(G)B J :=7A : #oint J 37 A = #oints J 87 A > #oints DICB !)T(2) I 9 #oints !)T(G) I ; #oints
)latelet count
Total
DA$$reviationsB O-H organ *ailureA !)T(2)H #atients &ith hemato#oeitic malignanciesA !)T(G)H #atients &ithout hemato#oeitic malignancies<
/+orin4
in+rease A ' 3oints* stron4 in+rease A . 3oints 6rolon4ed 6T& B. se+ A 5 3oints* @. B( A 1 3oint* @( A ' 3oints Fi:rino4en level& @1 487 A 5 3oints* B1 A 1 3oint
2al+ulate s+ore
Greater than or eDual to % A +om3ati:le with overt 0,2* re3eat s+orin4 daily 7ess than % su44estive of non9overt 0,2
I* E 8B com#ati$le &ith over t DICA re#eat scoring (ail" Throm$ !aemost< I* F 8B suggestive (not a**irmative) *or non'overt DICA re#eat ne?t :'= (a"sANov =77:A35(8)B:>=;'>7
&en'obatan KID
%an(asan #engo$atan KID a(alah #engo$atan on(isi
"ang men(asarin"a
C C C C
mengulangi tes untu memantau secara (inamis $eru$ah s enario "ang (i(asar an #a(a hasil la$oratorium (an #engamatan linis<
ABC D
Thank you